SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics -- Ignore unavailable to you. Want to Upgrade?


To: Davidoff who wrote (1110)7/25/2025 11:37:40 AM
From: luckydog88  Read Replies (1) | Respond to of 1227
 
market agrees with you for now.

but its been a few weeks since we got this :)

BENZINGA

Jul-25-2025 7:47 a.m. ET

D. Boral Capital analyst Jason Kolbert maintains ImmunityBio (IBRX) with a Buy and maintains $30 price target.